By uniting dosing analytics with clinical decision support, the combined platform accelerates the adoption of precision medicine and strengthens DoseMe’s competitive edge in the rapidly growing digital health and MIPD market.
DoseMe, a Jupiter, FL‑based model‑informed precision dosing software provider, announced the acquisition of Firstline, a Vancouver‑based clinical decision‑support platform. The deal, undisclosed in value, aims to create a unified experience from therapy selection through personalized dosing.
Comments
Want to join the conversation?
Loading comments...